Dabrafenib Effective in Pediatric Glioma

    Cancer Discovery
    |January 8, 2017
    PubMed
    Summary

    Dabrafenib shows promise in treating pediatric low-grade gliomas with the BRAF V600E mutation, offering durable responses and fewer side effects than chemotherapy. Further trials are investigating combination therapy for broader BRAF-mutant tumors.